# emids Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/emids-technologies

- Industry: Healthcare IT
- Headquarters: Franklin, US
- Website: www.emids.com
- Total disclosed funding: $13M
- Latest round: Series A (Nov 1, 2013)
- Investors on record: 2

## About

Emids Technologies Inc is a US-based company that specializes in providing advanced technology solutions to enhance healthcare delivery and operational efficiency for various healthcare organizations.Founded in 1999 in Franklin, US, Emids Technologies Inc focuses on transforming healthcare through technology solutions. The company was established by Saurabh Sinha, who has previous entrepreneurial experience. In 2020, Emids raised USD 13.30 mn in a Series A funding round, with notable investors including Baird Capital Partners and Council Capital. This funding reflects the company's strategic commitment to expanding its technological offerings and capabilities in healthcare.Emids offers a suite of advanced technology solutions aimed at improving healthcare delivery and operational efficiency. Their core product, Agentic AI, helps healthcare organizations identify AI use cases, accelerate prototype launches, and implement scalable solutions while ensuring compliance. They also provide generative AI consulting, design-led engineering, data engineering, and automation services. The company serves payers, providers, health tech companies, and life sciences organizations across North America, Europe, and parts of Asia, focusing on optimizing costs and improving patient care.In 2018, Emids achieved a revenue of USD 95.00 mn through a combination of subscription-based services and project-based engagements. The company collaborates with clients to provide tailored solutions, fostering long-term partnerships and facilitating ongoing service agreements that include consulting and engineering projects.Emids plans to leverage recent funding to develop new products and enhance existing services. The company aims to expand into new markets, specifically targeting regions in Europe and Asia by 2023. The latest funding round will support these initiatives, enabling Emids to innovate further and meet the growing demands of the healthcare technology sector. Recent investments, including the one from BlueCross BlueShield Venture Partners in March 2020, highlight the ongoing interest in the company's growth potential.

## Funding rounds

- Series A, Nov 1, 2013, $13M — Baird Capital Partners, Council Capital

## Investors

- Baird Capital Partners (https://capitalatlas.ai/funds/baird-capital-partners) — Series A
- Council Capital (https://capitalatlas.ai/funds/council-capital) — Series A